Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sanzhar Shalekenov"'
Autor:
Gulmira Kulmambetova, Botakoz Kurentay, Alua Gusmaulemova, Talgat Utupov, Dana Auganova, Pavel Tarlykov, Meiram Mamlin, Saule Khamzina, Sanzhar Shalekenov, Arman Kozhakhmetov
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectivesFusobacterium nucleatum is a gram-negative anaerobic bacillus associated with colorectal cancer (CRC). We aimed to determine the abundance of F. nucleatum and other CRC-associated bacteria using quantitative real-time polymerase chain react
Externí odkaz:
https://doaj.org/article/21763e570dc34e13819fbdd6aea2243c
Publikováno v:
Ķazaķstannyṇ Klinikalyķ Medicinasy, Vol 20, Iss 5, Pp 65-67 (2023)
Syphilitic hepatitis is a rare clinical presentation of syphilis and is easily misdiagnosed. However, clinical and histopathologic manifestations of Syphilitic Hepatitis can imitate other infectious and non-infectious diseases, and the diagnosis shou
Externí odkaz:
https://doaj.org/article/d975f3a6de184581800050d616656803
Autor:
Sanzhar Shalekenov, Atiqullah Aziz, Arndt Hartmann, Julius Schäfer, Johannes Breyer, Eva Maria Lausenmeyer, Christian Giedl, Stefan Denzinger, Bastiaan W.G. van Rhijn, Matthias Evert, Johannes Bründl, Maximilian Burger, Wolfgang Otto
Publikováno v:
Bladder Cancer (Amsterdam, Netherlands)
Objectives: To investigate the predictive impact of the proliferation biomarker Ki-67 on the clinical course of patients with initial stage pTa urothelial carcinoma of the bladder (UCB). Methods: We retrospectively analyzed all patients treated by tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de3dada38861df76e9537714d905f271
https://doi.org/10.3233/blc-170103
https://doi.org/10.3233/blc-170103
Autor:
Michael Gierth, Wolfgang Otto, Atiqullah Aziz, Stefan Denzinger, Sanzhar Shalekenov, Ferdinand Hofstädter, Maximilian Burger, Julius Schäfer, Christian Giedl, Johannes Breyer
Publikováno v:
World journal of urology. 34(5)
To determine whether the immunohistochemical markers survivin and E-cadherin can predict progress at initially diagnosed Ta bladder cancer. We retrospectively searched for every initially diagnosed pTa urothelial bladder carcinoma having been treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9103127fe5ad0c3363bd4f92ba019acb
https://pubmed.ncbi.nlm.nih.gov/26394624
https://pubmed.ncbi.nlm.nih.gov/26394624